Mounjaro, a relatively new drug approved by the FDA in May 2023, is generating significant attention within the medical community for its effectiveness to treat Type 2 diabetes. While not a cure, Mounjaro appears to be offering substantial benefits in managing blood sugar levels and reducing the need for other medications. Early trials show promisi